{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:52:12Z","timestamp":1791845532471,"version":"4.3.4"},"reference-count":73,"publisher":"American Society for Microbiology","issue":"12","license":[{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100000774","name":"DOD | Defense Threat Reduction Agency","doi-asserted-by":"publisher","award":["HDTRA1-14-C-0122"],"award-info":[{"award-number":["HDTRA1-14-C-0122"]}],"id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000774","name":"DOD | Defense Threat Reduction Agency","doi-asserted-by":"publisher","award":["JSTO CB-3848"],"award-info":[{"award-number":["JSTO CB-3848"]}],"id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:p><jats:named-content content-type=\"genus-species\">Burkholderia pseudomallei<\/jats:named-content>, the etiological agent of melioidosis, is a Gram-negative bacterium with additional concern as a biothreat pathogen. The mortality rate from<jats:named-content content-type=\"genus-species\">B. pseudomallei<\/jats:named-content>varies depending on the type of infection and extent of available health care; in the case of septicemia, left untreated, it can range from 50% to 90%. Current therapy for melioidosis is biphasic, consisting of parenteral acute-phase treatment for 2 weeks or longer, followed by oral eradication-phase treatment lasting several months.<\/jats:p>","DOI":"10.1128\/aac.00834-19","type":"journal-article","created":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T09:41:51Z","timestamp":1568799711000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":8,"title":["GC-072, a Novel Therapeutic Candidate for Oral Treatment of Melioidosis and Infections Caused by Select Biothreat Pathogens"],"prefix":"10.1128","volume":"63","author":[{"given":"Jeffry D.","family":"Shearer","sequence":"first","affiliation":[{"name":"Emergent BioSolutions, Gaithersburg, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle L.","family":"Saylor","sequence":"additional","affiliation":[{"name":"Emergent BioSolutions, Gaithersburg, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Butler","sequence":"additional","affiliation":[{"name":"Emergent BioSolutions, Gaithersburg, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony M.","family":"Treston","sequence":"additional","affiliation":[{"name":"Emergent BioSolutions, Gaithersburg, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry S.","family":"Heine","sequence":"additional","affiliation":[{"name":"Institute for Therapeutic Innovation, University of Florida, College of Medicine, Orlando, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunisa","family":"Chirakul","sequence":"additional","affiliation":[{"name":"Emerging Pathogens Institute, University of Florida, College of Medicine, Gainesville, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert P.","family":"Schweizer","sequence":"additional","affiliation":[{"name":"Institute for Therapeutic Innovation, University of Florida, College of Medicine, Orlando, Florida, USA"},{"name":"Emerging Pathogens Institute, University of Florida, College of Medicine, Gainesville, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"Louie","sequence":"additional","affiliation":[{"name":"Institute for Therapeutic Innovation, University of Florida, College of Medicine, Orlando, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George L.","family":"Drusano","sequence":"additional","affiliation":[{"name":"Institute for Therapeutic Innovation, University of Florida, College of Medicine, Orlando, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Zumbrun","sequence":"additional","affiliation":[{"name":"United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly L.","family":"Warfield","sequence":"additional","affiliation":[{"name":"Emergent BioSolutions, Gaithersburg, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.17-0885"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.107"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.18.2.383-416.2005"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1204699"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nmicrobiol.2015.8"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005923"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000900"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(00)90333-X"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6976.2009.00189.x"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.1.584-587.2003"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.2002.02957.x"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.47596-0"},{"key":"e_1_3_3_14_2","unstructured":"NIAID. 2018. NIAID emerging infectious disease\/pathogens. https:\/\/www.niaid.nih.gov\/research\/emerging-infectious-diseases-pathogens. Accessed 27 June 2018."},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.2807\/esm.10.03.00528-en"},{"key":"e_1_3_3_16_2","unstructured":"CDC. 2018. Excluded strains of HHS and USDA select agents and toxins. Federal Select Agent Program. https:\/\/www.selectagents.gov\/SelectAgentsandToxinsExclusions.html. Accessed 22 October 2018."},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1586\/eri.10.4"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2014.01.005"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1812.120638"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.12.6032-6034.2005"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1991.00400030135027"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.68.2.261"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.2.970-972.2005"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1086\/595011"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2014.04.007"},{"key":"e_1_3_3_26_2","unstructured":"WHO. 5 February 2018. Antibiotic resistance. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antibiotic-resistance. Accessed 10 January 2019."},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2014.06.003"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.3.465"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.2217\/fmb.12.116"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01803-09"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00440-06"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05517-11"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2016.07.003"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01657-08"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S35529"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030789"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.7.2082-2087.2003"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00010-17"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00356-17"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-28843-7"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1111020108"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00305"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000519"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01842-13"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.000358"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036507"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00660-13"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01357-17"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw529"},{"key":"e_1_3_3_50_2","first-page":"229","volume-title":"Melioidosis: a century of observation and research","author":"Schweizer HP","year":"2012","unstructured":"Schweizer HP. 2012. Mechanisms of Burkholderia pseudomallei antimicrobial resistance, p 229\u2013238. In Ketheesan N (ed), Melioidosis: a century of observation and research. Elsevier, Amsterdam, Netherlands."},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1086\/428051"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(97)90044-4"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1086\/428052"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.000475"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199958002-00003"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.200800041"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1002\/1098-1128(200007)20:4<231::AID-MED1>3.0.CO;2-N"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm990191k"},{"key":"e_1_3_3_59_2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2174\/138161280302221006114505","article-title":"Quinolones, 2-pyridones and resistant Type II DNA topoisomerases","volume":"3","author":"Shen L","year":"1997","unstructured":"Shen L. 1997. Quinolones, 2-pyridones and resistant Type II DNA topoisomerases. Curr Pharm Des 3:169\u2013176.","journal-title":"Curr Pharm Des"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2016.10.008"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm960207w"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01513-09"},{"key":"e_1_3_3_63_2","volume-title":"Assessment of Burkholderia Pseudomallei (bp) in vitro susceptbility and efficacy in a murine-aerosol challenge model for five antibiotic classes","author":"Heine H","year":"2009","unstructured":"Heine H, Miller L, Halasohoris S, Holman K, Zadeh M. 2009. Assessment of Burkholderia Pseudomallei (bp) in vitro susceptbility and efficacy in a murine-aerosol challenge model for five antibiotic classes, abstr B-1333. Abstr 49th ICAAC, 12\u201315 September 2009. American Society for Microbiology, San Francisco, CA."},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.179.7.2116-2125.1997"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01313-09"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2011.00139"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1002\/0471141755.ph0303s57"},{"key":"e_1_3_3_68_2","volume-title":"Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria","author":"CLSI","year":"2010","unstructured":"CLSI. 2010. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria, 2nd ed, vol. 30, no. 18. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"2"},{"key":"e_1_3_3_69_2","volume-title":"Twenty-fifth informal supplement M100-S25","author":"CLSI","year":"2015","unstructured":"CLSI. 2015. Performance standards for antimicrobial susceptibility testing. Twenty-fifth informal supplement M100-S25. Clinical and Laboratory Standards Institute, Wayne, PA."},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-017-1040-4"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-8502(73)90006-2"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vascn.2003.07.001"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajplegacy.1947.150.1.70"},{"key":"e_1_3_3_74_2","first-page":"61","volume-title":"Biodefense research methodology and animal models","author":"Roy CJ","year":"2006","unstructured":"Roy CJ, Pitt LM. 2006. Infectious disease aerobiology: aerosol challenge methods, p 61\u201376. In Swearengen JR (ed), Biodefense research methodology and animal models. CRC Press, Boca Raton, FL."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00834-19","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00834-19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T12:42:42Z","timestamp":1695213762000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00834-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":73,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["10.1128\/AAC.00834-19"],"URL":"https:\/\/doi.org\/10.1128\/aac.00834-19","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"2019-04-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00834-19"}}